RE:RE:Suggestion
I understand the offer from PLI is a binding offer. Which means , to me, there is no chance of another one unless the shareholders turn it down. I agree with you that it is unlikely that will happen. However, if it did happen the stock price would probably plummet minus another offer. In this whole sorry mess I blame the FDA. They encouraged the company to apply with the existing stats and then they screwed us.